Hofseth BioCare ASA (OSL:HBC)
1.325
-0.005 (-0.38%)
Mar 10, 2026, 10:02 AM CET
Hofseth BioCare ASA Cash Flow Statement
Financials in millions NOK. Fiscal year is January - December.
Millions NOK. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Net Income | -134.88 | -125.3 | -106.68 | -137.39 | -126.46 | Upgrade
|
| Depreciation & Amortization | 39.41 | 32.79 | 29.87 | 24.41 | 25.72 | Upgrade
|
| Other Amortization | - | 6.99 | 6.54 | 5.81 | 3.63 | Upgrade
|
| Loss (Gain) From Sale of Assets | - | -8.12 | -23.49 | - | - | Upgrade
|
| Asset Writedown & Restructuring Costs | - | - | - | 0.19 | - | Upgrade
|
| Loss (Gain) on Equity Investments | -2.15 | 7.48 | 2.54 | -0.2 | -0.03 | Upgrade
|
| Other Operating Activities | 77.44 | 159.68 | 9.49 | 9.95 | 9.39 | Upgrade
|
| Change in Accounts Receivable | -2.67 | -4 | -0.78 | -3.98 | 4.18 | Upgrade
|
| Change in Inventory | -3.91 | 26.63 | 33.98 | -25.71 | -17.51 | Upgrade
|
| Change in Accounts Payable | 0.99 | 38.47 | -90.59 | 70.36 | 39.21 | Upgrade
|
| Change in Other Net Operating Assets | 10.16 | -144.4 | 141.87 | 11.4 | 0.1 | Upgrade
|
| Operating Cash Flow | -15.61 | -9.78 | 2.76 | -45.17 | -61.78 | Upgrade
|
| Capital Expenditures | -25.31 | -2.44 | -8.19 | -4.02 | -22.92 | Upgrade
|
| Sale (Purchase) of Intangibles | -0.73 | -1.63 | -5.87 | -13.76 | -14.83 | Upgrade
|
| Investment in Securities | - | - | -1.62 | - | -0.19 | Upgrade
|
| Other Investing Activities | - | -0 | 0.69 | - | - | Upgrade
|
| Investing Cash Flow | -26.04 | -4.07 | -14.99 | -17.78 | -37.94 | Upgrade
|
| Short-Term Debt Issued | - | 19.4 | 28.35 | - | - | Upgrade
|
| Long-Term Debt Issued | 133.46 | 25.1 | - | - | 1.09 | Upgrade
|
| Total Debt Issued | 133.46 | 44.5 | 28.35 | - | 1.09 | Upgrade
|
| Long-Term Debt Repaid | -26.36 | -12.98 | -14.18 | -15.05 | -14.89 | Upgrade
|
| Net Debt Issued (Repaid) | 107.11 | 31.52 | 14.17 | -15.05 | -13.8 | Upgrade
|
| Issuance of Common Stock | - | - | - | 70.78 | - | Upgrade
|
| Other Financing Activities | -23.98 | -15.98 | -10.48 | -10.28 | -9.39 | Upgrade
|
| Financing Cash Flow | 83.13 | 15.54 | 3.69 | 45.45 | -23.2 | Upgrade
|
| Miscellaneous Cash Flow Adjustments | - | 0 | - | - | 0 | Upgrade
|
| Net Cash Flow | 41.47 | 1.69 | -8.54 | -17.49 | -122.91 | Upgrade
|
| Free Cash Flow | -40.92 | -12.22 | -5.43 | -49.19 | -84.7 | Upgrade
|
| Free Cash Flow Margin | -15.96% | -4.60% | -2.49% | -40.84% | -96.67% | Upgrade
|
| Free Cash Flow Per Share | -0.10 | -0.03 | -0.01 | -0.13 | -0.24 | Upgrade
|
| Cash Interest Paid | 22.83 | 15.69 | 9.49 | 9.95 | 9.39 | Upgrade
|
| Levered Free Cash Flow | -19.53 | 21.85 | -100.88 | -72.21 | -65.15 | Upgrade
|
| Unlevered Free Cash Flow | -5.26 | 31.66 | -96.16 | -65.99 | -59.28 | Upgrade
|
| Change in Working Capital | 4.57 | -83.31 | 84.49 | 52.06 | 25.97 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.